AshleyElizabethFrithMD

PubMed

• 9 citations
  Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
  Andrew A Davis, Jingqin Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong, Lu Tan, Rama Suresh, Foluso O Ademuyiwa, Caron Rigden, Timothy P Rearden, Katherine Clifton, Kather...> ;Clinical Cancer Research. 2023 May 1
• 2 citations
  A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
  Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis Levine, Jingqin Luo, Yu Tao, Jeremy Hoog, Marie L Laury, Tracy Summa, Trish Hammerschmidt, Zhanfang Guo,...> ;NPJ Breast Cancer. 2023 Jan 6
• 3 citations
  A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.
  Jairam Krishnamurthy, Jingqin Luo, Rama Suresh, Foluso Ademuyiwa, Caron Rigden, Timothy Rearden, Katherine Clifton, Katherine Weilbaecher, Ashley Frith, Anna Roshal, P...> ;NPJ Breast Cancer. 2022 Mar 21
• 21 citations
  Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer
  Foluso O. Ademuyiwa, Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk, Gejae Jeffers, Zachary L. Skidmore, Anamika Basu, Megan Richters, Cynthia...> ;Breast Cancer Research and Treatment. 2021 Jun 26
• 5 citations
  Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography
  Quing Zhu, Foluso O. Ademuyiwa, Catherine A. Young, Catherine M. Appleton, Matthew F. Covington, Cynthia X. Ma, S Sanati, Ian S. Hagemann, Atahar Mostafa, K. M. Shihab...> ;Breast Cancer Research and Treatment. 2021 May 10
• 7 citations
  Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma
  Brian A. Van Tine, Angela C. Hirbe, Peter Oppelt, Ashley Frith, Richa Rathore, Joshua D. Mitchell, Fei Wan, Shellie Berry, Michele Landeau, George A. Heberton, John Go...> ;Clinical Cancer Research. 2021 Jul 15
• 2 citations
  Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)
  Katherine Clifton, Jingqin Luo, Yu Tao, Jennifer Saam, Thereasa A. Rich, Anna Roshal, Ashley Frith, Caron Rigden, Foluso O. Ademuyiwa, Katherine N. Weilbaecher, Leonel...> ;Breast Cancer Research and Treatment. 2021 Feb 1
• 56 citations
  Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer.
  Jing Xi, Aabha Oza, Shana Thomas, Foluso O. Ademuyiwa, Katherine N. Weilbaecher, Rama Suresh, Ron Bose, Mathew Cherian, Leonel Hernandez-Aya, Ashley Frith, Lindsay L. ...> ;Journal of the National Comprehensive Cancer Network. 2019 Feb 1
• 12 citations
  Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
  Polly A. Niravath, Susan G. Hilsenbeck, Tao Wang, Sao Jiralerspong, Julie R. Nangia, Anne Pavlick, Foluso O. Ademuyiwa, Ashley Frith, Cynthia X. Ma, Haeseong Park, Car...> ;Breast Cancer Research and Treatment. 2019 Jun 19
• 25 citations
  Novel Pathways and Molecular Targets for the Treatment of Sarcoma
  Ashley Frith, Angela C. Hirbe, Brian A. Van Tine> ;Current Oncology Reports. 2013 May 10
• Join now to see all